Diagnostic challenges in hepatic metastatic olfactory neuroblastoma: a case report and literature review.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
open liver resection
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Histomorphological and immunohistochemical findings, in conjunction with the patient's clinical history, confirmed the diagnosis of hepatic metastasis from ONB. [CONCLUSION] Hepatic metastasis of ONB can closely mimic primary liver cancer on imaging, underscoring the necessity of integrating comprehensive clinical history, imaging assessment, and pathological confirmation to avoid misdiagnosis.
[BACKGROUND] Olfactory neuroblastoma (ONB) is a rare malignant tumor arising from the nasal cavity and paranasal sinuses, often presenting diagnostic challenges due to its potential for recurrence and
APA
He K, Wen D, et al. (2026). Diagnostic challenges in hepatic metastatic olfactory neuroblastoma: a case report and literature review.. Discover oncology. https://doi.org/10.1007/s12672-026-04689-8
MLA
He K, et al.. "Diagnostic challenges in hepatic metastatic olfactory neuroblastoma: a case report and literature review.." Discover oncology, 2026.
PMID
41904722
Abstract
[BACKGROUND] Olfactory neuroblastoma (ONB) is a rare malignant tumor arising from the nasal cavity and paranasal sinuses, often presenting diagnostic challenges due to its potential for recurrence and distant metastasis, particularly to uncommon sites such as the liver.
[CASE PRESENTATION] We report the case of a 42-year-old female with a history of ONB who was admitted after a liver mass was detected during routine examinations at another hospital two months earlier. The lesion was initially misdiagnosed as primary hepatocellular carcinoma based on imaging findings from contrast-enhanced ultrasound, enhanced CT, and MRI, which revealed a focal lesion in liver segments S5/6. Laboratory results showed slightly elevated AFP (8.91 ng/ml) and CA19-9 (37.12 U/ml), with no other significant abnormalities. The patient subsequently underwent open liver resection.
[RESULTS] Postoperative pathological examination revealed a malignant small round blue cell tumor. Histomorphological and immunohistochemical findings, in conjunction with the patient's clinical history, confirmed the diagnosis of hepatic metastasis from ONB.
[CONCLUSION] Hepatic metastasis of ONB can closely mimic primary liver cancer on imaging, underscoring the necessity of integrating comprehensive clinical history, imaging assessment, and pathological confirmation to avoid misdiagnosis.
[CASE PRESENTATION] We report the case of a 42-year-old female with a history of ONB who was admitted after a liver mass was detected during routine examinations at another hospital two months earlier. The lesion was initially misdiagnosed as primary hepatocellular carcinoma based on imaging findings from contrast-enhanced ultrasound, enhanced CT, and MRI, which revealed a focal lesion in liver segments S5/6. Laboratory results showed slightly elevated AFP (8.91 ng/ml) and CA19-9 (37.12 U/ml), with no other significant abnormalities. The patient subsequently underwent open liver resection.
[RESULTS] Postoperative pathological examination revealed a malignant small round blue cell tumor. Histomorphological and immunohistochemical findings, in conjunction with the patient's clinical history, confirmed the diagnosis of hepatic metastasis from ONB.
[CONCLUSION] Hepatic metastasis of ONB can closely mimic primary liver cancer on imaging, underscoring the necessity of integrating comprehensive clinical history, imaging assessment, and pathological confirmation to avoid misdiagnosis.
같은 제1저자의 인용 많은 논문 (5)
- Discovery of potent kinase inhibitors with improved pharmacokinetics and safety potentials through structural optimization of dasatinib.
- Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung).
- Cinnamic Acid Ameliorates Myocardial Injury Caused by Arsenic Trioxide in Rats by Modulating Oxidative Stress and Inflammatory Response.
- Immunotherapy's new prospects and clinical difficulties in BRAF-mutated acral melanoma.
- Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model.